Related Experiment Video

Updated: Aug 7, 2026

Amide Hydrogen/Deuterium Exchange & MALDI-TOF Mass Spectrometry Analysis of Pak2 Activation
07:15

Amide Hydrogen/Deuterium Exchange & MALDI-TOF Mass Spectrometry Analysis of Pak2 Activation

Published on: November 26, 2011

Physical and functional interactions between protein tyrosine phosphatase alpha, PI 3-kinase, and PKCdelta

A Steták1, P Csermely, A Ullrich

  • 1Department of Medical Chemistry, Peptide Biochemistry Research Group, Semmelweis University, Budapest, H-1088, Hungary. stetak@hotmail.com

Biochemical and Biophysical Research Communications
|October 26, 2001
PubMed

Insights

The somatostatin analogue TT-232 triggers anti-tumor effects by activating the Erk/MAPK pathway. This involves a complex of PI 3-kinase, PKCdelta, and PTPalpha, crucial for inhibiting tumor cell growth.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • The somatostatin analogue TT-232 demonstrates anti-cancer properties by inhibiting tumor cell proliferation and inducing apoptosis.
  • The precise signaling cascade responsible for TT-232-induced Erk/MAPK pathway activation, essential for cell cycle arrest, remained unclear.

Purpose of the Study:

  • To elucidate the signaling pathway involved in TT-232-mediated activation of the Erk/MAPK pathway.
  • To investigate the roles of PI 3-kinase, PKCdelta, and PTPalpha in this signaling cascade.

Main Methods:

  • Investigating the involvement of PI 3-kinase, PKCdelta, and PTPalpha in TT-232's mechanism of action.
  • Demonstrating physical interactions between PI 3-kinase, PKCdelta, and PTPalpha.
  • Assessing the role of PTPalpha phosphorylation at Ser-180 and Ser-204 in phosphatase activity and pp60(c-src) dephosphorylation.

Main Results:

  • TT-232-induced Erk/MAPK pathway activation involves PI 3-kinase, PKCdelta, and PTPalpha.
  • A physical association exists between PI 3-kinase, PKCdelta, and PTPalpha.
  • PTPalpha phosphorylation at Ser-180 and Ser-204 is critical for its phosphatase activity, leading to pp60(c-src) dephosphorylation and mediating anti-tumor effects.

Conclusions:

  • A signaling complex comprising PI 3-kinase, PKCdelta, and PTPalpha mediates the anti-tumor activity of TT-232.
  • This complex activates the Erk/MAPK pathway, contributing to TT-232's efficacy against tumor cells.

More Related Videos

Assaying Protein Kinase Activity with Radiolabeled ATP08:05

Assaying Protein Kinase Activity with Radiolabeled ATP

Published on: May 26, 2017

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes09:40

Co-immunoprecipitation Assay for Studying Functional Interactions Between Receptors and Enzymes

Published on: September 28, 2018

Related Concept Videos

Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...